Advisory Services Network, LLC Aldeyra Therapeutics, Inc. Transaction History

Advisory Services Network, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$1.47 - $6.06 $735 - $3,030	500 New	500 $1,000
Q3 2021 Nov 05, 2021	SELL	$7.94 - $11.31 $8,853 - $12,610	-1,115 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$10.44 - $14.85 $11,640 - $16,557	1,115 New	1,115 $13,000
Q1 2021 May 24, 2021	SELL	$6.53 - $14.42 $7,280 - $16,078	-1,115 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$4.0 - $7.53 $4,460 - $8,395	1,115 New	1,115 $8,000

116

36.2M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $285M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.